Status:
COMPLETED
Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Dentsply International
Conditions:
Irreversible Pulpitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this trial is to study the ability of a frequently used dental anesthetic (articaine) to achieve complete numbness of a diseased tooth with the most commonly used injection technique in...
Detailed Description
The goal of the study is to achieve complete pulpal anesthesia in irreversible pulpitis mandibular molars, either by IANB administration of 4% articaine with 1:100,000 epinephrine (NDA 022466), or in ...
Eligibility Criteria
Inclusion
- adult patients
- irreversible pulpitis in mandibular molar
Exclusion
- below 18 years
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT01496846
Start Date
September 1 2011
End Date
February 1 2016
Last Update
October 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan, School of Dentistry Clinics
Ann Arbor, Michigan, United States, 48109